Spatial Omics is revolutionizing biological research, with the market expected to surge from USD 457.2 million in 2024 to USD 3.12 billion by 2033, at a CAGR of 23.7%. This rapid growth is driven by the rise of spatial transcriptomics, precision oncology demand, and robust public R&D funding.